(Total Views: 136)
Posted On: 07/13/2023 8:45:46 AM
Post# of 62
$MBRX News Article - Moleculin Announces Publication of Data from Successful European Phase 1 Trial Evaluating Annamycin as Single Agent Treatment of Relapsed or Refractory Acute Myeloid Leukemia (AML) https://marketwirenews.com/news-releases/mole...05385.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
